CN109331080A - The pharmaceutical composition and preparation method thereof for treating acute upper respiratory infection - Google Patents

The pharmaceutical composition and preparation method thereof for treating acute upper respiratory infection Download PDF

Info

Publication number
CN109331080A
CN109331080A CN201811301692.8A CN201811301692A CN109331080A CN 109331080 A CN109331080 A CN 109331080A CN 201811301692 A CN201811301692 A CN 201811301692A CN 109331080 A CN109331080 A CN 109331080A
Authority
CN
China
Prior art keywords
parts
preparation
pharmaceutical composition
borneol
menthol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201811301692.8A
Other languages
Chinese (zh)
Inventor
袁建平
吕艳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
YUNNAN KANGCHUANG BIOPHARMACEUTICAL TECHNOLOGY INCUBATION Co Ltd
Original Assignee
YUNNAN KANGCHUANG BIOPHARMACEUTICAL TECHNOLOGY INCUBATION Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by YUNNAN KANGCHUANG BIOPHARMACEUTICAL TECHNOLOGY INCUBATION Co Ltd filed Critical YUNNAN KANGCHUANG BIOPHARMACEUTICAL TECHNOLOGY INCUBATION Co Ltd
Priority to CN201811301692.8A priority Critical patent/CN109331080A/en
Publication of CN109331080A publication Critical patent/CN109331080A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/35Caprifoliaceae (Honeysuckle family)
    • A61K36/355Lonicera (honeysuckle)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/233Bupleurum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/287Chrysanthemum, e.g. daisy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/61Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/78Saururaceae (Lizard's-tail family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/04Drugs for disorders of the respiratory system for throat disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a kind of pharmaceutical composition and preparation method thereof for treating acute upper respiratory infection, the composition contains following drug: honeysuckle, wild chrysanthemum, cordate houttuynia, radix bupleuri, menthol, borneol, eucalyptus oil.Pharmaceutical composition all medicines share provided by the invention has effects that inducing diaphoresis heresy, throat, dispelling wind heat, and sample is simultaneously controlled, and tonification and purgation in combination, curative for effect.The present invention is used for acute upper respiratory infection, abscess of throat and bronchial asthma, has significant curative effect to diseases such as chronic bronchitis, acute and chronic bronchitis asthma.

Description

The pharmaceutical composition and preparation method thereof for treating acute upper respiratory infection
Technical field
The present invention relates to a kind of pharmaceutical compositions and preparation method thereof for treating acute upper respiratory infection.
Background technique
The usual infection of the upper respiratory tract refers to the general name from nasal cavity to the acute inflammation between throat, is the most common breathing system System disease can betide the crowd at any age, and mostly season in spring and autumn is fallen ill.The disease belongs to respiratory tract infection scope.If treatment Not in time, easily cause tracheae and pulmonary infection, the tablet of conventional pharynx-clearing throat-benefiting sometimes can only respite pain symptom, But it fundamentally can't resolve illness that is clearing heat and detoxicating, removing stasis.
That therefore, it is necessary to develop a kind of components is simple, production is simple, can multi-form medication, good effect and have no toxic side effect Chinese medicine composition.Achieve the purpose that quality-high and inexpensive economic and practical.
Summary of the invention
It is an object of the present invention to provide a kind of pharmaceutical compositions and preparation method thereof for treating acute upper respiratory infection.
Realize that the technical solution of the object of the invention is as follows:
A kind of pharmaceutical composition for treating acute upper respiratory infection contains following drug: honeysuckle, wild chrysanthemum, fish raw meat Grass, radix bupleuri, menthol, borneol, eucalyptus oil.
Preferably, described pharmaceutical composition contains the drug of following parts by weight: 100-150 parts of honeysuckle, wild chrysanthemum 100- 150 parts, 100-150 parts of cordate houttuynia, 100-150 parts of radix bupleuri, 0.5-1.5 parts of menthol, 0.1-0.9 parts of borneol, 1-3 parts of eucalyptus oil.
It is further preferred that described pharmaceutical composition contains the drug of following parts by weight: 110-135 parts of honeysuckle, mother chrysanthemum 110-135 parts of flower, 110-135 parts of cordate houttuynia, 110-135 parts of radix bupleuri, 0.8-1.2 parts of menthol, 0.3-0.7 parts of borneol, eucalyptus oil 1.5-2.5 part.
It is further preferred that described pharmaceutical composition contains the drug of following parts by weight: 125 parts of honeysuckle, wild chrysanthemum 125 parts, 125 parts of cordate houttuynia, 125 parts of radix bupleuri, 1 part of menthol, 0.5 part of borneol, 2 parts of eucalyptus oil.
The above-mentioned eucalyptus oil of the present invention is myrtle blue gum Eucalyptus globulus LabilL., lauraceae plant Two section of camphor tree Cinnamomum camphora (L.) Presl or above-mentioned belongs to the volatile oil that other plant is extracted through steam distillation, Meet States Pharmacopoeia specifications.
Parts by weight of the present invention can be the unit of weight well known in the art such as μ g, mg, g, kg, be also possible to it again Number, such as 1/10,1/100,10 times, 100 times.
The present invention also provides the preparation methods of aforementioned pharmaceutical compositions, comprising the following steps: takes drug according to the ratio;By gold and silver Flower, wild chrysanthemum, cordate houttuynia, radix bupleuri carry out steam distillation after adding suitable quantity of water to impregnate, collect distillate;Menthol, borneol are used Ethanol in proper amount dissolution, adds eucalyptus oil, mixing is sufficiently stirred, be added in above-mentioned distillate, add when stirring, and mixes, filtering, i.e., ?.
The present invention also provides the preparation containing aforementioned pharmaceutical compositions, said preparation is by described pharmaceutical composition and pharmaceutically may be used The carrier of receiving forms.
The pharmaceutically acceptable carrier includes one or more of purified water, distilled water, ethyl alcohol, Tween-80 etc..
The preparation is preferably spray, aerosol, solution, mixture etc..
The present invention also provides the methods for preparing above-mentioned preparation, method includes the following steps: by described pharmaceutical composition It is uniformly mixed with carrier, is made according to a conventional method.
It is further preferred that the preparation is spray, it is made of the ingredient for including following parts by weight: 125 parts of honeysuckle, 125 parts of wild chrysanthemum, 125 parts of cordate houttuynia, 125 parts of radix bupleuri, 1 part of menthol, 0.5 part of borneol, 2 parts of eucalyptus oil.
Preferably, the preparation method of the spray the following steps are included: take drug according to the ratio;By honeysuckle, wild chrysanthemum, Cordate houttuynia, radix bupleuri carry out steam distillation after adding suitable quantity of water to impregnate, collect distillate;Menthol, borneol ethanol in proper amount is molten Solution, adds eucalyptus oil and appropriate Tween-80, mixing is sufficiently stirred, be added in above-mentioned distillate, add when stirring, and mixes, mistake Filter to get being made 1000 parts altogether.
Preferably, the soaking time is 2-6 hours.
Further, every 1mL preparation is equivalent to crude drug 0.5g.
The present invention also provides aforementioned pharmaceutical compositions or preparation in the drug of preparation treatment acute upper respiratory infection Application.
Pharmaceutical composition of the present invention or preparation inducing diaphoresis heresy, throat, dispelling wind heat.It is particularly suitable for treating on acute and exhale Inhale road infection, abscess of throat.
The invention has the advantages that:
Throat is belonging to lung stomach, and wind-heat poison heresy follows mouth and nose and invades lung stomach, and throat stands in the breach, and the evil knot of poison is in throat, train of thought It is impaired, it mutually wins and does not go, therefore abscess of throat, belong to Chinese medicine anemopyretic tonsillitis or anemopyretic laryngalgia scope.Pharmaceutical composition provided by the invention In object, with honeysuckle, chrysanthemum, cordate houttuynia it is clearing heat and detoxicating based on, be monarch drug in a prescription;Radix bupleuri inducing diaphoresis is thoroughly evil, and principal drug assistance inducing diaphoresis is diathermanous, is minister Medicine;Menthol makees excitants, acts on skin or mucous membrane, has refrigerant antipruritic, wind dispelling to relieve pain, promote blood circulation, mitigate edema Deng, borneol resuscitation with aromatics, dispelling wind and heat from the body, the refrigerant bactericidal effect of eucalyptus oil, help medicine-feeding expelling wind to resolve the exterior, reducing pharyngeal swelling of having one's ideas straightened out, be adjutant. Cordate houttuynia is pungent, slightly cold, distributed in lung channel, except clearing heat and detoxicating in addition to monarch drug in a prescription, it is main enter lung channel, be apt to clearing lung-heat heat, draw all medicines and act on heat-clearing solution Poison, the carbuncle that disappears apocenosis, and to make medicine.Inducing diaphoresis heresy, throat, dispelling wind heat are played altogether in full side.For acute upper respiratory infection, throat is swollen Bitterly.
All medicines share of the present invention has effects that inducing diaphoresis heresy, throat, dispelling wind heat, and sample is simultaneously controlled, and tonification and purgation in combination, curative effect Definitely.The present invention is used for acute upper respiratory infection, abscess of throat and bronchial asthma, to chronic bronchitis, acute and chronic branch The diseases such as san bronchial asthma have significant curative effect.
Specific embodiment
The following examples are used to illustrate the present invention, but are not intended to limit the scope of the present invention..It is not specified in embodiment specific Technology or conditions person, described technology or conditions according to the literature in the art, or carried out according to product description.It is used Production firm person is not specified in reagent or instrument, is the conventional products that can be commercially available by regular distributor.
Embodiment 1
A kind of pharmaceutical composition (spray) for treating acute upper respiratory infection, is made: honeysuckle of ingredient below 125g, wild chrysanthemum 125g, cordate houttuynia 125g, radix bupleuri 125g, menthol 1g, borneol 0.5g, eucalyptus oil 2mL.
Every 1mL spray is equivalent to crude drug 0.5g.
Preparation method includes: to take above seven taste according to the ratio, adds appropriate amount of water to impregnate honeysuckle, wild chrysanthemum, cordate houttuynia, radix bupleuri Steam distillation is carried out after 4 hours, collects distillate about 800mL, it is spare.Menthol, borneol are dissolved with ethanol in proper amount, then divided Not Jia Ru eucalyptus oil and appropriate Tween-80, mixing is sufficiently stirred;Then, it is added in above-mentioned distillate while stirring, mixes, filtering, Spray 1000mL is made, dispenses to obtain the final product.
Embodiment 2
A kind of pharmaceutical composition (spray) for treating acute upper respiratory infection, is made: honeysuckle of following component 120g, wild chrysanthemum 120g, cordate houttuynia 120g, radix bupleuri 120g, menthol 1g, borneol 0.5g, eucalyptus oil 2ml.
Preparation method is same as Example 1.
Embodiment 3
A kind of pharmaceutical composition (spray) for treating acute upper respiratory infection, is made: honeysuckle of following component 130g, wild chrysanthemum 130g, cordate houttuynia 130g, radix bupleuri 130g, menthol 1g, borneol 0.5g, eucalyptus oil 2ml.
Preparation method is same as Example 1.
Embodiment 4
A kind of pharmaceutical composition (spray) for treating acute upper respiratory infection, is made: honeysuckle of following component 110g, wild chrysanthemum 110g, cordate houttuynia 110g, radix bupleuri 110g, menthol 1g, borneol 0.5g, eucalyptus oil 2ml.
Preparation method is same as Example 1.
Embodiment 5
A kind of pharmaceutical composition (spray) for treating acute upper respiratory infection, is made: honeysuckle of following component 125g, wild chrysanthemum 125g, cordate houttuynia 125g, radix bupleuri 125g, menthol 0.9g, borneol 0.5g, eucalyptus oil 3ml.
Preparation method is same as Example 1.
Comparative example 1
Pharmaceutical composition (spray), is made of following component: wild chrysanthemum 125g, radix bupleuri 125g, menthol 1g, borneol 0.5g, eucalyptus oil 2mL.Preparation method is (difference is only that raw material does not include honeysuckle and cordate houttuynia) same as Example 1.
Experimental example 1
Laboratory sample: the pharmaceutical composition (spray) for the treatment of acute upper respiratory infection prepared by embodiment 1;
Control sample 1: pharmaceutical composition (spray) prepared by comparative example 1;
Control sample 2: ice connects Qingyan Spray, and (component is rheum officinale, boron to Chenzhou Sanjiu Medical & Pharmaceutical Co., Ltd.'s production Sand, indigo naturalis, borneol, menthol, saltcake, the coptis, honeysuckle, turmeric, Radix Glycyrrhizae).
Experimental method:
207 medical patients are chosen, patient has different degrees of bottleneck throat pain itch, dry, cough and expectoration, foreign matter The symptoms such as sense, phonopathy, wherein male 105, women 102;Year at age (35.74 ± 14.61).It is randomly divided into control group 1 (using control sample 1, oral cavity injection, spray 3 times is pressed in sucking on the 1st, and one time 1-2 is pressed, and is used in conjunction 5), control group 2 (use control Sample 2, one time 5 spray, 6 times a day, the course for the treatment of be 5 days), test group (use example 1 drug composition, oral cavity injection, sucking, Spray 3 times is pressed within 1st, one time 1-2 is pressed, and is used in conjunction 5), every group of 69 people.
Gender, age, severity extent are statistically analyzed respectively, and there was no significant difference.Tobacco and wine are disabled during treatment With pungent stimulation food.
Curative effect judging standard is drafted according to " new Chinese medicine guideline of clinical investigations ".Cure: symptom mitigates in 3d, fills Blood, swelling disappear, no abnormalities feel;Effective: symptom and sign improves in 3d;Effective: symptom and sign improves in treatment 3-5d;Nothing Effect: symptom and sign is without improvement in treatment 5d.Experimental result see the table below.
As the result is shown: 1 treated effect of control group is only 78.3%, and the effective percentage of control group 2 is 89.8%, and experimental group has Efficiency is 92.8%;Show that experimental group cure rate is significantly larger than other groups, inefficiency is also lower with respect to other, and has conspicuousness Difference.It can be seen that the present invention is in terms for the treatment of acute upper respiratory infection, abscess of throat, effect is better than the prior art.
Experimental example 2
The pharmaceutical composition (spray) prepared with embodiment 1 carries out 472 patients in 6 months for laboratory sample Treatment.
Treatment method: oral cavity injection, sucking press spray 3 times on the 1st, press for one time 1~2, be used in conjunction 5.
Effect standard:
Recovery from illness: abscess of throat symptom disappears, and upper respiratory tract infection symptoms disappear;
Effective: abscess of throat symptom disappears, upper respiratory tract mild infection;
Effective: abscess of throat, upper respiratory tract infection symptoms slightly mitigate;
Invalid: abscess of throat, upper respiratory tract infection symptoms mitigate, and do not change.
Through counting, as a result are as follows: effective 176, account for the 37.3% of total patient;Effective 148, account for the 31.4% of total patient; The patient of recovery from illness is 145, accounts for the 30.7% of total patient;Invalid 3, the 0.6% of total patient, in effective and effective case Only 2 are not cured;Total effective rate is 99.4%.
Typical case:
1, Huang, male, 20 years old, on June 11st, 2017 symptoms include fever and headache were had sore throat, the sliding number of pulse condition and float, tongue fur Bao Bai, tongue body side point is red, and tonsillotome is red and swollen.Doctor suggests making using this product (medicinal composition spray prepared by embodiment 1) After 2 days, symptom is obviously improved, and is fully recovered after 5 days.
2, certain is thanked, female 21 years old, facilitates outpatient clinic, main suit's dysphagia on May 28th, 2017 to our hospital, throat itches, Swelling and pain, fried chicken was eaten before 2 days, every other day again eaten pineapple and ice watermelon, diagnosis is acute upper respiratory infection, after issue This product (medicinal composition spray prepared by embodiment 1), began to use, symptom is alleviated within second day, disease after 3 days in the same day Shape thoroughly disappears;
3, Lee, male, 35 years old, on April 5th, 2012 examined, and main suit generated heat 37.5 DEG C from yesterday, and nasal obstruction flows yellow tears, had a headache, pharynx Larynx swelling and pain, red tip of tongue, moss thin yellow, superficial and rapid pulse.Doctor is recommended to use this product (medicinal composition spray prepared by embodiment 1), After 2 days, illness disappears.
It is attached: spray quality standard of the present invention
[character] this product is milky emulsion liquid or colourless clear liquid, has special aroma.
[identification] takes this product as test solution.Borneol reference substance separately is taken, adds ethyl acetate that every 1ml is made containing 1mg's Solution, as reference substance solution.It is tested according to thin-layered chromatography (" Chinese Pharmacopoeia "), draws this product and each 5 μ l of reference substance solution, point Other point is on the same silica gel g thin-layer plate using sodium carboxymethylcellulose as binder, with petroleum ether (60~90 DEG C)-acetic acid second Ester-benzene (9: 1: 2) is solvent, is unfolded, and takes out, dries, and it is aobvious to be heated to spot at 105 DEG C with 10% phosphomolybdic acid ethanol for spray Color is clear.In sample chromatogram, on reference substance chromatography corresponding position, identical blue spot should be shown.
[inspection] should meet related every regulation under " Chinese Pharmacopoeia " spray item.
[major function] inducing diaphoresis heresy, throat, dispelling wind heat.For abscess of throat;Above-mentioned card is shown in acute upper respiratory infection Hou Zhe.
The injection of [usage and dosage] oral cavity, sucking.Spray 3 times is pressed within 1st, presses, or follows the doctor's advice for one time 1~2.
[specification] every 1ml is equivalent to medicine materical crude slice 0.5g.
[storage] is closed, sets cool dark place.
Although above the present invention is described in detail with a general description of the specific embodiments, On the basis of the present invention, it can be made some modifications or improvements, this will be apparent to those skilled in the art.Cause This, these modifications or improvements, fall within the scope of the claimed invention without departing from theon the basis of the spirit of the present invention.

Claims (10)

1. a kind of pharmaceutical composition for treating acute upper respiratory infection, which is characterized in that contain following drug: honeysuckle, it is wild Chrysanthemum, cordate houttuynia, radix bupleuri, menthol, borneol, eucalyptus oil.
2. pharmaceutical composition according to claim 1, which is characterized in that the drug containing following parts by weight: honeysuckle 100-150 parts, 100-150 parts of wild chrysanthemum, 100-150 parts of cordate houttuynia, 100-150 parts of radix bupleuri, 0.5-1.5 parts of menthol, borneol 0.1-0.9 parts, 1-3 parts of eucalyptus oil.
3. pharmaceutical composition according to claim 1, which is characterized in that the drug containing following parts by weight: honeysuckle 110-135 parts, 110-135 parts of wild chrysanthemum, 110-135 parts of cordate houttuynia, 110-135 parts of radix bupleuri, 0.8-1.2 parts of menthol, borneol 0.3-0.7 parts, 1.5-2.5 parts of eucalyptus oil.
4. pharmaceutical composition according to claim 1, which is characterized in that the drug containing following parts by weight: honeysuckle 125 Part, 125 parts of wild chrysanthemum, 125 parts of cordate houttuynia, 125 parts of radix bupleuri, 1 part of menthol, 0.5 part of borneol, 2 parts of eucalyptus oil.
5. the preparation method of any one of claim 1-4 described pharmaceutical composition, which comprises the following steps: by matching Than taking drug;Steam distillation is carried out after adding suitable quantity of water to impregnate honeysuckle, wild chrysanthemum, cordate houttuynia, radix bupleuri, collects distillate; Menthol, borneol are dissolved with ethanol in proper amount, eucalyptus oil is added, mixing is sufficiently stirred, be added in above-mentioned distillate, when stirring Add, mix, filtering to get.
6. the preparation of the described in any item pharmaceutical compositions of 1-4 containing claim, said preparation is by pharmaceutical composition and pharmaceutically may be used The carrier of receiving forms.
7. preparation according to claim 6, which is characterized in that the preparation is spray, aerosol, solution or conjunction Agent.
8. preparation according to claim 7, which is characterized in that the preparation is spray, by including following parts by weight Ingredient is made: 125 parts of honeysuckle, 125 parts of wild chrysanthemum, and 125 parts of cordate houttuynia, 125 parts of radix bupleuri, 1 part of menthol, 0.5 part of borneol, eucalyptus 2 parts of oil;Preferably, every 1mL spray is equivalent to crude drug 0.5g.
9. the preparation method of preparation described in claim 8, which comprises the following steps: take drug according to the ratio;By gold and silver Flower, wild chrysanthemum, cordate houttuynia, radix bupleuri carry out steam distillation after adding suitable quantity of water to impregnate, collect distillate;Menthol, borneol are used Ethanol in proper amount dissolution, adds eucalyptus oil and appropriate Tween-80, mixing is sufficiently stirred, be added in above-mentioned distillate, when stirring Add, mix, filters to get 1000 parts are made altogether.
10. the described in any item pharmaceutical compositions of claim 1-4 or claim 5 the method preparation pharmaceutical composition or The described in any item preparations of claim 6-8 or the preparation of claim 9 the method preparation are in the acute upper breathing of preparation treatment Application in the drug of road infection.
CN201811301692.8A 2018-11-02 2018-11-02 The pharmaceutical composition and preparation method thereof for treating acute upper respiratory infection Pending CN109331080A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811301692.8A CN109331080A (en) 2018-11-02 2018-11-02 The pharmaceutical composition and preparation method thereof for treating acute upper respiratory infection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811301692.8A CN109331080A (en) 2018-11-02 2018-11-02 The pharmaceutical composition and preparation method thereof for treating acute upper respiratory infection

Publications (1)

Publication Number Publication Date
CN109331080A true CN109331080A (en) 2019-02-15

Family

ID=65313457

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811301692.8A Pending CN109331080A (en) 2018-11-02 2018-11-02 The pharmaceutical composition and preparation method thereof for treating acute upper respiratory infection

Country Status (1)

Country Link
CN (1) CN109331080A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1615923A (en) * 2003-11-12 2005-05-18 成都三明药物研究所 Medicinal composition and its preparing method and use
CN1857343A (en) * 2006-04-11 2006-11-08 徐蕾 Chinese medicine composition for preventing and treating viral cold and throat disease and its preparing method
CN102512533A (en) * 2011-12-16 2012-06-27 曲靖开发区格力康生物科技发展有限公司 Traditional Chinese medicine composition for treating swelling and pain in throat and preparation thereof
CN104666431A (en) * 2015-02-16 2015-06-03 广西双蚁药业有限公司 Traditional Chinese medicine preparation for treating acute upper respiratory tract infection and production method of traditional Chinese medicine preparation

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1615923A (en) * 2003-11-12 2005-05-18 成都三明药物研究所 Medicinal composition and its preparing method and use
CN1857343A (en) * 2006-04-11 2006-11-08 徐蕾 Chinese medicine composition for preventing and treating viral cold and throat disease and its preparing method
CN102512533A (en) * 2011-12-16 2012-06-27 曲靖开发区格力康生物科技发展有限公司 Traditional Chinese medicine composition for treating swelling and pain in throat and preparation thereof
CN104666431A (en) * 2015-02-16 2015-06-03 广西双蚁药业有限公司 Traditional Chinese medicine preparation for treating acute upper respiratory tract infection and production method of traditional Chinese medicine preparation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
罗斌等: "中药经皮给药佐治小儿肺炎1624例临床观察 ", 《儿科药学杂志》 *

Similar Documents

Publication Publication Date Title
CN102319294B (en) Double-vanilla preparation and preparation method thereof
CN106421039A (en) Traditional Chinese medicine composition for preventing and treating haze-caused diseases, preparation method thereof and mask containing traditional Chinese medicine
CN101584810B (en) Medicine composition for treating gastritis and peptic ulcer and preparation method thereof
CN101537055A (en) Swine enzootic pneumonia treatment recipe, preparation method and liquid medicine using method
CN102362965A (en) Formula with sounding effect and preparation method thereof
CN101843682A (en) Maxingshigan injecta and preparation method thereof
CN100534526C (en) Chinese medicine for treating respiratory disease
CN113995821B (en) Chinese medicinal composition for treating pneumonia caused by novel coronavirus and other viruses, preparation and preparation method thereof
CN109331080A (en) The pharmaceutical composition and preparation method thereof for treating acute upper respiratory infection
CN105412281A (en) Traditional Chinese medicinal composition for treating allergic asthma and preparation method thereof
CN105832848A (en) Traditional Chinese medicine composition for poultry respiratory diseases and preparation method thereof
CN104958727B (en) A kind of Chinese medicine composition for treating the childhood asthma paracmasis and its application
CN104740581B (en) A kind of application of cold asthma patch of fragrant fiber crops and its detection method
CN1025478C (en) Nose liniment and preparing process
JP5265347B2 (en) Use of konjac and its extract in formulating pharmaceuticals for the treatment of acute and chronic bronchitis
CN110585281B (en) Children and adults common traditional Chinese medicine preparation for treating phlegm-heat obstructing lung and preparation method thereof
CN104127544B (en) The application in preparing medicine of Murraya tetramera Huang and extract thereof
CN102908607A (en) External traditional Chinese medicine for treating chronic simple rhinitis and preparation method thereof
CN107753626A (en) A kind of medicine for reducing isoprenaline hydrochloride side effect
CN104547501A (en) Children traditional Chinese medicine formula for treating acute nasosinusitis
CN105194545B (en) A kind of Chinese medicine composition for treating asthma
CN114949147A (en) Traditional Chinese medicine composition for treating chronic pharyngitis as well as preparation method and application thereof
CN116531457A (en) Traditional Chinese medicine composition for treating chronic pharyngitis and application thereof
CN114732889A (en) Traditional Chinese medicine composition and traditional Chinese medicine oral preparation for treating bronchial asthma acute attack stage turbid phlegm lung obstruction syndrome
CN103990027B (en) A kind of atomized liquid for respiratory tract inhalation injury

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
TA01 Transfer of patent application right
TA01 Transfer of patent application right

Effective date of registration: 20200318

Address after: 655000 Biomedical Health Industry Science Park, No. 51 Ruihe West Road, Qujing City, Yunnan Province

Applicant after: Yunnan health testing inspection technology Co., Ltd

Address before: 655000 Biomedical Health Industry Science Park, No. 51 Ruihe West Road, Qujing City, Yunnan Province

Applicant before: YUNNAN KANGCHUANG BIOLOGICAL MEDICAL TECHNOLOGY HATCHING Co.,Ltd.

WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20190215